Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Significance: Obesity and metabolic syndrome may, in part, originate in fetal life. In particular, babies of mothers with obesity and/or gestational diabetes mellitus (GDM) are often large at birth and have increased adiposity, which predisposes them to the development of metabolic disease later in life. Maternal obesity and GDM are typically associated with low circulating levels of adiponectin (ADN), and we found that ADN supplementation to pregnant obese mice completely normalized the changes in placental function and prevented fetal overgrowth caused by maternal obesity. These findings suggest that strategies to increase ADN levels in maternal obesity and GDM may alleviate the adverse effects of these pregnancy complications on the fetus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Activation of the cellular energy sensor AMPK mediates the effects of ADN on glucose transport and fatty acid oxidation in the liver and muscle (41).”
BackgroundPajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778 · cited 1×
“O and the metabolic syndrome are major risk factors for a wide array of diseases, including type 2 diabetes mellitus, cardiovascular disease, and cancer (1, 2).”
BackgroundA small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · cited 2×
“These findings, together with the recent discovery of an orally active ADN receptor agonist (AdipoRon) (18), provide the rationale for exploring the possibility that maternal ADN supplementation may prevent the adverse fetal outcomes in maternal obesity.”
BackgroundThe influence of obesity and diabetes on the prevalence of macrosomia
Ehrenberg, H. M., Mercer, B. M., & Catalano, P. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.052 · Cited by 670 · cited 1×
“Obesity in pregnant women is associated with activation of placental insulin and mechanistic target of rapamycin complex 1 (mTORC1) signaling, up-regulation of specific placental amino acid transporters, and fetal overgrowth (6, 7).”
BackgroundPhosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598 · cited 2×
“Insulin receptor substrate-1 (IRS-1) is known to be activated by phosphorylation at Tyr608 and inhibited by phosphorylation at Ser307 (23).”
BackgroundJansson, N., Rosario, F. J., Gaccioli, F., Lager, S., Jones, H. N., Roos, S., Jansson, T., & Powell, T. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2667 · Cited by 305 · cited 4×
“Unlike classical insulin-sensitive tissues, such as adipose, muscle, and liver, where insulin function is impaired by metabolic disease, placental insulin signaling has been reported to be activated in pregnancies associated with obesity or diabetes (6, 38).”
BackgroundSelf-citationWilliams, M. A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., & Luthy, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031201 · Cited by 220
Rosario, F. J., Kanai, Y., Powell, T. L., & Jansson, T. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238014 · Cited by 185 · cited 5×
“mTORC1 is a key positive regulator of placental amino acid transport (24, 25), and placental mTORC1 signaling has been reported to be activated in obese women (6) and rodents fed a high-fat diet (40).”
BackgroundSelf-citationJones, H. N., Jansson, T., & Powell, T. L. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00195.2009 · Cited by 168 · cited 1×
“SNAT2 represents a highly regulated system A isoform in the placenta (25, 35, 36) and in other tissues (37).”
BackgroundSelf-citation
Cited by
Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring
Buffington, S. A., Di Prisco, G. V., Auchtung, T. A., Ajami, N. J., Petrosino, J. F., & Costa-Mattioli, M. (2016) · Cell · doi:10.1016/j.cell.2016.06.001 · Cited by 1,163
“Social Behaviors are Impaired in MHFD Offspring To investigate how maternal diet-induced obesity affects offspring neurodevelopment, femalemicewere fed either regular diet (RD) or high-fat diet (HFD) for 8 weeks, a standard period required to reach a state of diet-induced obesity in mice (Aye et al., 2015).”
The endocrine function of adipose tissues in health and cardiometabolic disease
Scheja, L., & Heeren, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0230-6 · Cited by 663
Developmental origins of metabolic diseases
Hoffman, D. J., Powell, T. L., Barrett, E. S., & Hardy, D. B. (2021) · Physiological Reviews · doi:10.1152/physrev.00002.2020 · Cited by 466
Self-citationPlacental Responses to Changes in the Maternal Environment Determine Fetal Growth
Dimasuay, K. G., Boeuf, P., Powell, T. L., & Jansson, T. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00012 · Cited by 258
Self-citationPlacental Function in Maternal Obesity
Kelly, A. C., Powell, T. L., & Jansson, T. (2020) · Clinical Science · doi:10.1042/cs20190266 · Cited by 227
“with fetal growth, implicating a role for adiponectin in regulation of maternal metabolism, placental function, and fetal development (54,58,59).”
BackgroundSelf-citationMoyce, B. L., & Dolinsky, V. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113467 · Cited by 128
“Currently, rodent models of GDM have shown that supplementation with adiponectin can improve glycemic control and insulin resistance [53,80]; however, this hasn’t been established in human pregnancy despite research showing a correlation between hypo-adiponectinemia and GDM [81].”
BackgroundSferruzzi-Perri, A. N., Lopez-Tello, J., Napso, T., & Yong, H. E. J. (2020) · Placenta · doi:10.1016/j.placenta.2020.01.015 · Cited by 58
Tumor necrosis factor- α, adiponectin and their ratio in gestational diabetes mellitus.
(2018) · Europe PMC (PubMed Central) · doi:10.22088/cjim.9.1.71 · Cited by 10
“Adiponectin infusion in pregnant mice results in a significant decrease in maternal values of leptin and insulin (24).”
Background
Metadata
- Authors
- Aye, I. L. M. H., Rosario, F. J., Powell, T. L., & Jansson, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2015-09-28
- Volume
- 112
- Issue
- 41
- Pages
- 12858-12863
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2129993215
- Cited by
- 160
- References
- 16
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.